Novel approach to treating glue ear could save children from surgery

March 6, 2013, Cardiff University
Novel approach to treating glue ear could save children from surgery

A new trial is underway to determine if a short course of oral steroids can improve the hearing of children suffering from glue ear, thanks to a £1.3M research grant awarded to scientists at Cardiff University.

is the most common reason for childhood surgery, with approximately 25,000 operations carried out each year in the UK. Also known as otitis media with effusion (OME), the condition is caused by an accumulation of sticky fluid in the middle ear and affects around 80% of by the age of four.

For most children, glue ear gets better by itself. But for thousands of children each year it results in that can affect speech, social development and learning. This in many cases leads to depression, as well as behavioural and attention disorders.

With a substantial award from the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme, researchers from Cardiff University's School of Medicine are now able to explore the use of steroids in treating this pervasive condition. Professor Chris Butler, Institute Director at Cardiff University's Cochrane Institute of Primary Care & Public Health, and leader of the study, said:

"Glue ear is an important cause of deafness and the most common reason for children to have an operation in the UK. If , which are commonly used as a treatment for asthma in children, prove to be effective, we will be able to offer parents a new treatment choice to improve their child's quality of life and that may avert the need for an operation. Such an approach is also likely to result in significant savings for the NHS."

Sarah Jones, a mother from Cardiff, reflects on her young daughter's experience of suffering from glue ear:

"My daughter was diagnosed with glue ear when she was seven months old and this resulted in mild hearing loss through her early years. This delayed her speech and language development and greatly affected her socially. I was forever apologising for her shyness and having to 'translate' what little she did say because people couldn't understand her."

"It was awful thinking of her being stuck in a confused muffled world. She is five years old now and thankfully with time, speech and language therapy and understanding teaching staff she is coming through the other side of it and is such a little chatterbox. Fortunately we've not had to consider grommet surgery for her but had we got to that point I know that I would most definitely prefer to have the choice of a non-invasive treatment."

Currently, children suffering with recurrent and chronic glue ear will be offered hearing aids, or a surgical operation to insert grommets into the eardrum to improve ventilation. Both have risks and side effects, are costly, and require repeated visits to hospital clinics.

The development of an alternative non-surgical treatment for glue ear, that can be used to treat children in the first four years of life by GPs, could potentially spare children and their families the need for an invasive surgical procedure.

Many oral medications, including antibiotics, antihistamines and decongestants do not work for glue ear. There are, however, sound scientific grounds for believing that steroids might be beneficial for this condition. Yet trials conducted so far have been either too small, of poor quality, or haven't assessed hearing as a research outcome. Consequently, researchers at Cardiff aim to elucidate the long and short term benefits of this potential treatment.

The OSTRICH trial (Oral Steroids for Resolution of otitis media with effusion OME in Children) starts in March 2013 and will be conducted over a three-year period. It aims to recruit 380 participants from six hospital sites. The sample will be large enough to determine whether oral steroids produce a meaningful improvement in children's hearing and thus obviate the overreliance on grommet operations.

Explore further: Potential new treatments for a common childhood hearing disorder

More information: The OSTRICH study
OSTRICH project summary

Related Stories

Potential new treatments for a common childhood hearing disorder

October 21, 2011
Scientists from the Medical Research Council’s Mammalian Genetics Unit have identified a potential new treatment for ‘glue ear’ – a common inflammatory condition in children that can cause temporary, but ...

Revolutionary biodegradable pellet targets glue ear infection

July 21, 2011
A revolutionary biodegradable pellet which slowly releases antibiotics into the middle ear could transform the lives of thousands of children who suffer from glue ear.

Recommended for you

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.